These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15585856)

  • 81. Bone marrow rejection linked to SHIP gene.
    Ahmad K
    Lancet Oncol; 2002 May; 3(5):263. PubMed ID: 12067793
    [No Abstract]   [Full Text] [Related]  

  • 82. Deficiency of lipid phosphatase SHIP enables long-term reconstitution of hematopoietic inductive bone marrow microenvironment.
    Liang OD; Lu J; Nombela-Arrieta C; Zhong J; Zhao L; Pivarnik G; Mondal S; Chai L; Silberstein LE; Luo HR
    Dev Cell; 2013 May; 25(4):333-49. PubMed ID: 23725762
    [TBL] [Abstract][Full Text] [Related]  

  • 83. SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammation.
    Maxwell MJ; Srivastava N; Park MY; Tsantikos E; Engelman RW; Kerr WG; Hibbs ML
    Genes Immun; 2014 Apr; 15(4):233-40. PubMed ID: 24598798
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Allogeneic T cell responses are regulated by a specific miRNA-mRNA network.
    Sun Y; Tawara I; Zhao M; Qin ZS; Toubai T; Mathewson N; Tamaki H; Nieves E; Chinnaiyan AM; Reddy P
    J Clin Invest; 2013 Nov; 123(11):4739-54. PubMed ID: 24216511
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Abortive activation of CD4 T cell responses during competitive priming in vivo.
    Weaver JM; Chaves FA; Sant AJ
    Proc Natl Acad Sci U S A; 2009 May; 106(21):8647-52. PubMed ID: 19423666
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Morphine inhibits the development of allogeneic immune responses in mouse lymph node.
    Maity R; Mukherjee R; Skolnick P
    Immunopharmacology; 1995 Mar; 29(2):175-83. PubMed ID: 7775160
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
    Zhou Z; French DL; Ma G; Eisenstein S; Chen Y; Divino CM; Keller G; Chen SH; Pan PY
    Stem Cells; 2010 Mar; 28(3):620-32. PubMed ID: 20073041
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1.
    De Wilde V; Van Rompaey N; Hill M; Lebrun JF; Lemaître P; Lhommé F; Kubjak C; Vokaer B; Oldenhove G; Charbonnier LM; Cuturi MC; Goldman M; Le Moine A
    Am J Transplant; 2009 Sep; 9(9):2034-47. PubMed ID: 19681826
    [TBL] [Abstract][Full Text] [Related]  

  • 89. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.
    Delano MJ; Scumpia PO; Weinstein JS; Coco D; Nagaraj S; Kelly-Scumpia KM; O'Malley KA; Wynn JL; Antonenko S; Al-Quran SZ; Swan R; Chung CS; Atkinson MA; Ramphal R; Gabrilovich DI; Reeves WH; Ayala A; Phillips J; Laface D; Heyworth PG; Clare-Salzler M; Moldawer LL
    J Exp Med; 2007 Jun; 204(6):1463-74. PubMed ID: 17548519
    [TBL] [Abstract][Full Text] [Related]  

  • 90. MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle.
    Guo J; Zhong L; Momeni MR
    Cell Biol Toxicol; 2024 Sep; 40(1):77. PubMed ID: 39283408
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Improving the efficacy of immunotherapy for colorectal cancer: Targeting tumor microenvironment-associated immunosuppressive cells.
    Zou D; Xin X; Xu Y; Xu H; Huang L; Xu T
    Heliyon; 2024 Aug; 10(16):e36446. PubMed ID: 39262952
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer.
    Husain K; Villalobos-Ayala K; Laverde V; Vazquez OA; Miller B; Kazim S; Blanck G; Hibbs ML; Krystal G; Elhussin I; Mori J; Yates C; Ghansah T
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892872
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation.
    Michniacki TF; Choi SW; Peltier DC
    Handb Exp Pharmacol; 2022; 272():209-243. PubMed ID: 34628553
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice.
    So EY; Sun C; Wu KQ; Dubielecka PM; Reginato AM; Liang OD
    Am J Physiol Cell Physiol; 2021 Sep; 321(3):C569-C584. PubMed ID: 34288720
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Selective deletion of SHIP-1 in hematopoietic cells in mice leads to severe lung inflammation involving ILC2 cells.
    Ye X; Zhang F; Zhou L; Wei Y; Zhang L; Wang L; Tang H; Chen Z; Kerr WG; Zheng T; Zhu Z
    Sci Rep; 2021 Apr; 11(1):9220. PubMed ID: 33911168
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Targeting SHIP1 and SHIP2 in Cancer.
    Pedicone C; Meyer ST; Chisholm JD; Kerr WG
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672717
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancreatic Cancer.
    Villalobos-Ayala K; Ortiz Rivera I; Alvarez C; Husain K; DeLoach D; Krystal G; Hibbs ML; Jiang K; Ghansah T
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291556
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.
    D'Aveni M; Notarantonio AB; Bertrand A; Boulangé L; Pochon C; Rubio MT
    Front Immunol; 2020; 11():989. PubMed ID: 32528476
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pan-SHIP1/2 inhibitors promote microglia effector functions essential for CNS homeostasis.
    Pedicone C; Fernandes S; Dungan OM; Dormann SM; Viernes DR; Adhikari AA; Choi LB; De Jong EP; Chisholm JD; Kerr WG
    J Cell Sci; 2020 Jan; 133(5):. PubMed ID: 31780579
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
    Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
    Front Immunol; 2019; 10():1399. PubMed ID: 31275326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.